Cargando…
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study
BACKGROUND: Extended-release buprenorphine (XRB) offers a novel approach to sustained monthly treatment for people who use opioids in criminal justice settings (CJS). This study explores the experiences of adults receiving XRB as a jail-to-community treatment. METHODS AND FINDINGS: In-depth qualitat...
Autores principales: | Cheng, Anna, Badolato, Ryan, Segoshi, Andrew, McDonald, Ryan, Malone, Mia, Vasudevan, Kumar, Badiei, Beita, Sugarman, Allison, Macdonald, Ross, Mangat, Jasdeep, Giftos, Jonathan, Lee, Joshua D., Tofighi, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800291/ https://www.ncbi.nlm.nih.gov/pubmed/35093164 http://dx.doi.org/10.1186/s13722-022-00288-4 |
Ejemplares similares
-
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021) -
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
por: Velasquez, Melissa, et al.
Publicado: (2019) -
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic
por: Duncan, Alexandra, et al.
Publicado: (2021) -
Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021
por: Thakrar, Ashish P., et al.
Publicado: (2021) -
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
por: Samuels, Elizabeth A., et al.
Publicado: (2022)